Cell therapy

4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector. It invests in, supports, and grows early-stage companies developing treatments in areas of high unmet medical need. The firm's team comprises leading advanced therapy scientists and experienced life science investors.

Jeito Capital is a leading global investment company focused on biopharmaceuticals. They finance and accelerate cutting-edge medical innovation with a patient benefit approach, supporting entrepreneurs through significant capital contributions and expert guidance.

Syncona is a FTSE250 company focused on founding, building, and funding healthcare companies. They aim to deliver transformational treatments for patients in areas of high unmet need, building a diversified portfolio of 20-25 globally leading life science businesses.